首页 > 最新文献

Herzschrittmachertherapie und Elektrophysiologie最新文献

英文 中文
[Letter to the editor]. [给编辑的信]。
Q4 Medicine Pub Date : 2025-03-01 Epub Date: 2025-03-03 DOI: 10.1007/s00399-025-01073-x
Walter Seeger
{"title":"[Letter to the editor].","authors":"Walter Seeger","doi":"10.1007/s00399-025-01073-x","DOIUrl":"10.1007/s00399-025-01073-x","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"96-97"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Catheter ablation in patients with heart failure-who benefits?] 心衰患者的导管消融——谁受益?]
Q4 Medicine Pub Date : 2025-03-01 Epub Date: 2025-01-30 DOI: 10.1007/s00399-025-01066-w
Leonard Bergau, Vanessa Sciacca, Christian Sohns

Atrial fibrillation (AF) ablation is associated with a lower likelihood of death and surgical heart failure (HF) interventions in patients with HF. This effect is mainly driven by reduced all cause and cardiovascular death following ablation. Ablation also results in improved left ventricular (LV) function, decreased AF burden and AF regression. The accumulated evidence contributed substantially to a class 1 indication for AF ablation in patients with AF and HF with reduced ejection fraction in the 2023 ACC/AHA/ACCP/HRS guidelines. Risk scores like the CASTLE-HTx risk score may help to identify patients with HF who will particularly benefit from catheter ablation. The absolute benefit of catheter ablation is more pronounced in high-risk patients and is sustained over time. Catheter ablation should be considered as first-line therapy with a definitive class 1 indication for many patients with HF, particularly those with advanced HF.

心房颤动(AF)消融与心衰(HF)患者较低的死亡和手术干预可能性相关。这种效果主要是由于消融后全因死亡和心血管死亡减少所致。消融术还可改善左室(LV)功能,减轻房颤负担和房颤消退。累积的证据在2023年ACC/AHA/ACCP/HRS指南中将房颤和心衰伴射血分数降低患者房颤消融列为1级指征。像CASTLE-HTx风险评分这样的风险评分可能有助于识别心衰患者,这些患者将特别受益于导管消融。导管消融的绝对益处在高危患者中更为明显,并且可以持续一段时间。对于许多心衰患者,特别是晚期心衰患者,导管消融应被视为具有明确1级指征的一线治疗。
{"title":"[Catheter ablation in patients with heart failure-who benefits?]","authors":"Leonard Bergau, Vanessa Sciacca, Christian Sohns","doi":"10.1007/s00399-025-01066-w","DOIUrl":"10.1007/s00399-025-01066-w","url":null,"abstract":"<p><p>Atrial fibrillation (AF) ablation is associated with a lower likelihood of death and surgical heart failure (HF) interventions in patients with HF. This effect is mainly driven by reduced all cause and cardiovascular death following ablation. Ablation also results in improved left ventricular (LV) function, decreased AF burden and AF regression. The accumulated evidence contributed substantially to a class 1 indication for AF ablation in patients with AF and HF with reduced ejection fraction in the 2023 ACC/AHA/ACCP/HRS guidelines. Risk scores like the CASTLE-HTx risk score may help to identify patients with HF who will particularly benefit from catheter ablation. The absolute benefit of catheter ablation is more pronounced in high-risk patients and is sustained over time. Catheter ablation should be considered as first-line therapy with a definitive class 1 indication for many patients with HF, particularly those with advanced HF.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"3-9"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143069630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Letter to the editor]. [致编辑的信]
Q4 Medicine Pub Date : 2025-03-01 Epub Date: 2025-03-03 DOI: 10.1007/s00399-025-01074-w
Bernd Lemke
{"title":"[Letter to the editor].","authors":"Bernd Lemke","doi":"10.1007/s00399-025-01074-w","DOIUrl":"10.1007/s00399-025-01074-w","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"98"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EP-Ausbildung in Österreich. 澳大利亚的教育。
Q4 Medicine Pub Date : 2025-03-01 DOI: 10.1007/s00399-024-01056-4
{"title":"EP-Ausbildung in Österreich.","authors":"","doi":"10.1007/s00399-024-01056-4","DOIUrl":"https://doi.org/10.1007/s00399-024-01056-4","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":"36 1","pages":"99-100"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143558626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Left bundle branch (area) pacing: lead positioning and implant criteria-step for step]. [左束支(区)起搏:导联定位及植入标准-一步一步]。
Q4 Medicine Pub Date : 2025-03-01 Epub Date: 2024-12-02 DOI: 10.1007/s00399-024-01060-8
Joern Schmitt, Till Althoff, Sonia Busch, K R Julian Chun, Tillman Dahme, Micaela Ebert, Heidi Estner, Melanie Gunawardene, Christian Heeger, Leon Iden, Henning Jansen, Victoria Johnson, Tilman Maurer, Andreas Rillig, Sascha Rolf, Philipp Sommer, Daniel Steven, Richard Roland Tilz, David Duncker

Left bundle branch area pacing is currently the most common form of physiological pacing prior to His bundle pacing. It is intended to prevent or correct the development of pacemaker-induced cardiomyopathy and is being used more and more frequently. In order to be able to perform this successfully, knowledge regarding the specific anatomy and radiological anatomy as well as the ECG criteria for left bundle branch pacing is required in addition to knowledge of the tools. In this article, the technical requirements and steps for successful implantation are summarized and pitfalls are highlighted.

在His束起搏之前,左束分支区域起搏是目前最常见的生理起搏形式。它的目的是防止或纠正心脏起搏器引起的心肌病的发展,并被越来越频繁地使用。为了能够成功地完成这项工作,除了了解工具外,还需要了解特定的解剖和放射解剖以及左束支起搏的ECG标准。本文总结了成功植入的技术要求和步骤,并指出了陷阱。
{"title":"[Left bundle branch (area) pacing: lead positioning and implant criteria-step for step].","authors":"Joern Schmitt, Till Althoff, Sonia Busch, K R Julian Chun, Tillman Dahme, Micaela Ebert, Heidi Estner, Melanie Gunawardene, Christian Heeger, Leon Iden, Henning Jansen, Victoria Johnson, Tilman Maurer, Andreas Rillig, Sascha Rolf, Philipp Sommer, Daniel Steven, Richard Roland Tilz, David Duncker","doi":"10.1007/s00399-024-01060-8","DOIUrl":"10.1007/s00399-024-01060-8","url":null,"abstract":"<p><p>Left bundle branch area pacing is currently the most common form of physiological pacing prior to His bundle pacing. It is intended to prevent or correct the development of pacemaker-induced cardiomyopathy and is being used more and more frequently. In order to be able to perform this successfully, knowledge regarding the specific anatomy and radiological anatomy as well as the ECG criteria for left bundle branch pacing is required in addition to knowledge of the tools. In this article, the technical requirements and steps for successful implantation are summarized and pitfalls are highlighted.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"82-90"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11882732/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Physiological pacing and heart failure : Hope or hype?] 生理起搏和心力衰竭:希望还是炒作?]
Q4 Medicine Pub Date : 2025-03-01 Epub Date: 2025-02-18 DOI: 10.1007/s00399-025-01070-0
Victoria Johnson, Carlos Antepara, Reza Wakili, Jörn Schmitt

The cornerstone of heart failure treatment consists of a four pillar drug therapy. Patients with existing heart failure and complete left bundle branch block, or patients with an indication for pacemaker therapy for bradycardia and heart failure, benefit from physiological stimulation. For patients with left bundle branch block and severely impaired left ventricular systolic pump function (HFrEF), cardiac resynchronisation therapy (CRT) has so far been the gold standard. However, it is now increasingly possible to stimulate the conduction system directly using new forms of stimulation and to achieve similar clinical results. At present, left bundle branch area pacing (LBBAP) is the form of stimulation most frequently investigated in clinical studies. A special situation arises in the case of pacemaker-induced cardiomyopathy with right ventricular apical pacing. Here, LBBAP is certainly a beacon of hope.

心力衰竭治疗的基石包括四大支柱药物治疗。存在心力衰竭和完全性左束支传导阻滞的患者,或有心脏起搏器治疗心动过缓和心力衰竭指征的患者,可从生理刺激中获益。对于左束分支阻滞和左心室收缩泵功能(HFrEF)严重受损的患者,心脏再同步治疗(CRT)迄今为止是金标准。然而,现在越来越有可能使用新的刺激形式直接刺激传导系统,并取得类似的临床结果。目前,左束支区起搏(LBBAP)是临床研究中最常用的刺激形式。一种特殊的情况出现在起搏器引起的心肌病与右心室起搏。在这方面,LBBAP无疑是希望的灯塔。
{"title":"[Physiological pacing and heart failure : Hope or hype?]","authors":"Victoria Johnson, Carlos Antepara, Reza Wakili, Jörn Schmitt","doi":"10.1007/s00399-025-01070-0","DOIUrl":"10.1007/s00399-025-01070-0","url":null,"abstract":"<p><p>The cornerstone of heart failure treatment consists of a four pillar drug therapy. Patients with existing heart failure and complete left bundle branch block, or patients with an indication for pacemaker therapy for bradycardia and heart failure, benefit from physiological stimulation. For patients with left bundle branch block and severely impaired left ventricular systolic pump function (HFrEF), cardiac resynchronisation therapy (CRT) has so far been the gold standard. However, it is now increasingly possible to stimulate the conduction system directly using new forms of stimulation and to achieve similar clinical results. At present, left bundle branch area pacing (LBBAP) is the form of stimulation most frequently investigated in clinical studies. A special situation arises in the case of pacemaker-induced cardiomyopathy with right ventricular apical pacing. Here, LBBAP is certainly a beacon of hope.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"21-27"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mobitz or Wenckebach, that is the question]. [莫比茨还是温克巴赫,这是个问题]。
Q4 Medicine Pub Date : 2025-03-01 Epub Date: 2025-02-18 DOI: 10.1007/s00399-025-01072-y
Harilaos Bogossian, Sebastian Robl, Bernd Lemke, Konstantinos Iliodromitis
{"title":"[Mobitz or Wenckebach, that is the question].","authors":"Harilaos Bogossian, Sebastian Robl, Bernd Lemke, Konstantinos Iliodromitis","doi":"10.1007/s00399-025-01072-y","DOIUrl":"10.1007/s00399-025-01072-y","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"78-81"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac strangulation by epicardial pacing wires in adults. 成人心外膜起搏导线致心脏绞窄。
Q4 Medicine Pub Date : 2025-03-01 Epub Date: 2025-01-14 DOI: 10.1007/s00399-024-01061-7
S Serge Barold, Carsten W Israel

Like children, adult patients with active or abandoned epicardial pacing leads are also at risk of developing life-threatening cardiac ischemia due to mechanical compression of the coronary arteries. As this complication is amenable to surgical removal, these patients require periodic evaluation for myocardial ischemia even if they are asymptomatic.

与儿童一样,使用有效或废弃的心外膜起搏导线的成人患者也有因机械压迫冠状动脉而发生危及生命的心脏缺血的风险。由于这种并发症可以手术切除,这些患者需要定期评估心肌缺血,即使他们没有症状。
{"title":"Cardiac strangulation by epicardial pacing wires in adults.","authors":"S Serge Barold, Carsten W Israel","doi":"10.1007/s00399-024-01061-7","DOIUrl":"10.1007/s00399-024-01061-7","url":null,"abstract":"<p><p>Like children, adult patients with active or abandoned epicardial pacing leads are also at risk of developing life-threatening cardiac ischemia due to mechanical compression of the coronary arteries. As this complication is amenable to surgical removal, these patients require periodic evaluation for myocardial ischemia even if they are asymptomatic.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"75-77"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142980719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Interfaces in cardiology : How rhythmologists and heart failure specialists work together to improve the prognosis]. [心脏病学中的接口:心律失常学家和心力衰竭专家如何共同努力改善预后]。
Q4 Medicine Pub Date : 2025-03-01 Epub Date: 2025-02-24 DOI: 10.1007/s00399-025-01075-9
Arian Sultan, Julia Vogler
{"title":"[Interfaces in cardiology : How rhythmologists and heart failure specialists work together to improve the prognosis].","authors":"Arian Sultan, Julia Vogler","doi":"10.1007/s00399-025-01075-9","DOIUrl":"10.1007/s00399-025-01075-9","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitteilungen aus der Arbeitsgruppe Elektrophysiologie und Rhythmologie (AGEP). 电生理学和节律学工作组(AGEP)。
Q4 Medicine Pub Date : 2025-03-01 DOI: 10.1007/s00399-025-01069-7
{"title":"Mitteilungen aus der Arbeitsgruppe Elektrophysiologie und Rhythmologie (AGEP).","authors":"","doi":"10.1007/s00399-025-01069-7","DOIUrl":"https://doi.org/10.1007/s00399-025-01069-7","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":"36 1","pages":"101-102"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143558631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Herzschrittmachertherapie und Elektrophysiologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1